Search results
Results from the WOW.Com Content Network
PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
Methyl benzoate is an organic compound. It is an ester with the chemical formula C 6 H 5 COOCH 3, sometimes abbreviated as PhCO 2 Me, where Ph and Me are phenyl and methyl, respectively. Its structure is C 6 H 5 −C(=O)−O−CH 3. It is a colorless liquid that is poorly soluble in water, but miscible with organic solvents.
Methyl 4-iodobenzoate, or methyl p-iodobenzoate, is an organic compound with the formula IC 6 H 4 COOCH 3. [3] It is the methyl ester of 4-iodobenzoic acid , or may also be viewed as an iodinated derivative of methyl benzoate .
Ethyl benzoate, C 9 H 10 O 2, is an ester formed by the condensation of benzoic acid and ethanol. It is a colorless liquid that is almost insoluble in water, but miscible with most organic solvents. It is a colorless liquid that is almost insoluble in water, but miscible with most organic solvents.
4-Bromobenzaldehyde, or p-bromobenzaldehyde, is an organobromine compound with the formula BrC 6 H 4 CHO. It is one of three isomers of bromobenzaldehyde . [ 3 ] It displays reactivity characteristic of benzaldehyde and an aryl bromide .
Monobromotoluene isomers [1] [2] [3] Common name Structure Systematic name: 1-bromo-2-methylbenzene 1-bromo-3-methylbenzene 1-bromo-4-methylbenzene Molecular formula: C 7 H 7 Br (C 6 H 4 BrCH 3) Molar mass: 171.03 g/mol Appearance colorless liquid colorless liquid white crystalline solid CAS number [95-46-5] [591-17-3]
The drugs would have been worth up to NZ$3.8 million, or $2.2 million USD, the customs agency said in a news release. The duffel bag and disguised drugs. / Credit: New Zealand Customs Service
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.